Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC
Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if getting chemotherapy with Gemcitabine and Cisplatin
(GC) for 2-4 cycles can help shrink the tumor before undergoing surgery and improves the
overall survival for high-grade upper tract urothelial carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Xiangya Hospital of Central South University
Collaborators:
Central South University Hunan Cancer Hospital Hunan Provincial People's Hospital The Third Xiangya Hospital of Central South University